Report overview
This report contains market size and forecasts of Memantine Hydrochloride Extended-Release Capsule in Global, including the following market information:
Global Memantine Hydrochloride Extended-Release Capsule Market Revenue, 2018-2023, 2023-2032, ($ millions)
Global top five companies in 2022 (%)
The global Memantine Hydrochloride Extended-Release Capsule market was valued at US$ million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period 2023-2032.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2032.
7mg Segment to Reach $ Million by 2032, with a % CAGR in next six years.
The global key manufacturers of Memantine Hydrochloride Extended-Release Capsule include Lundbeck, Allergan, Novartis AG, Lupin Ltd, Huahai Pharmaceutical, Daiichi Sankyo Company Limited, Rottendorf Pharma GmbH, Polygen Pharms and Macleods Pharms Ltd, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Memantine Hydrochloride Extended-Release Capsule companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Memantine Hydrochloride Extended-Release Capsule Market, by Type, 2018-2023, 2023-2032 ($ millions)
Global Memantine Hydrochloride Extended-Release Capsule Market Segment Percentages, by Type, 2022 (%)
7mg
14mg
21mg
28mg
Others
Global Memantine Hydrochloride Extended-Release Capsule Market, by Application, 2018-2023, 2023-2032 ($ millions)
Global Memantine Hydrochloride Extended-Release Capsule Market Segment Percentages, by Application, 2022 (%)
Home
Hospital
Clinic
Others
Global Memantine Hydrochloride Extended-Release Capsule Market, By Region and Country, 2018-2023, 2023-2032 ($ Millions)
Global Memantine Hydrochloride Extended-Release Capsule Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Memantine Hydrochloride Extended-Release Capsule revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Memantine Hydrochloride Extended-Release Capsule revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lundbeck
Allergan
Novartis AG
Lupin Ltd
Huahai Pharmaceutical
Daiichi Sankyo Company Limited
Rottendorf Pharma GmbH
Polygen Pharms
Macleods Pharms Ltd
Amneal Pharms
Apeloa Pharmaceutical
HUMANWELL GROUP
Eisai Co
Ono Pharmaceutical Co Ltd
Slate Run
